U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07946354) titled 'Atropine vs Hyoscine N-Butylbromide for CRBD' on Nov. 09.

Brief Summary: Catheter-related bladder discomfort (CRBD) is a frequent postoperative complication associated with urinary catheterization. The purpose of this prospective, randomized, double-blind, placebo-controlled trial was to compare intravenous atropine, hyoscine N-butylbromide, and placebo for the prevention of CRBD in adults undergoing transurethral resection of the prostate or bladder tumors under general anesthesia.

The study interventions consisted of intravenous atropine 0.015 mg/kg, hyoscine N-butylbromide 20 mg, or an equivalent volume of 0.9% sodium chloride s...